-- Remiges Ventures, a US-based cross-border venture capital firm with offices 
in Seattle, WA and Tokyo, Japan, announced today the final closing of its 
second fund, Remiges BioPharma Fund II raising a total of $95 million, and the 
launch of RDiscovery, a new life sciences incubator to nurture and advance 
early-stage therapeutic concepts and technologies.

Remiges Ventures, a US-based cross-border venture capital firm with offices in 
Seattle, WA and Tokyo, Japan, announced today the final closing of its second 
fund, Remiges BioPharma Fund II raising a total of $95 million by welcoming new 
and returning investors, including Taiho Pharmaceutical Co., Ltd. (Tokyo, 
Japan), 1Globe Capital, LLC (Boston, MA), EA Pharma Co., Ltd. (Tokyo, Japan) 
and Senju Pharmaceutical Co., Ltd. (Osaka, Japan).

Remiges is also delighted to announce the launch of RDiscovery, a new life 
sciences incubator to nurture and advance early-stage therapeutic concepts and 
technologies with the goal of bringing them to a more mature stage of 
development. RDiscovery will operate as a wholly owned subsidiary of Remiges 
Ventures, allowing for an efficient and seamless transition of projects from 
pre-seed, early development to a stage where company formation and investment 
syndication makes sense. RDiscovery will serve as an integrated innovation 
engine extending the capacity and capabilities of Remiges Ventures to execute 
on its strategy of harnessing novel science from Japanese academia and 
launching it on a patient-centered and commercially-focused path.

"We are extremely pleased to close our second fund with six major healthcare 
companies both in the US and Japan and establish RDiscovery a new life science 
incubator," commented Taro Inaba, Founder and Managing Partner of Remiges 
Ventures. "The team is delighted to be working under our unique cross-border 
strategy to build new companies based on innovative seed technologies invented 
by researchers at Japanese academia and investing in early-stage companies 
globally."

About Remiges Ventures

Remiges Ventures ( 
https://c212.net/c/link/?t=0&l=en&o=3122843-1&h=3524799584&u=http%3A%2F%2Fwww.remigesventures.com%2F&a=Remiges+Ventures 
) focuses on company creation and investments in early-stage drug discovery and 
development companies. With its team located in the US and Japan, Remiges 
Ventures understands the drug discovery and biotech environments in both 
regions and marries the entrepreneurship and biotech ecosystem in the US with 
Japan's rich life science innovation. Additionally, with a limited partner base 
that includes Japanese and US healthcare companies, Remiges Ventures possesses 
a unique vantage point from which it creates and mines opportunities.

CONTACT:
Walter Olesiak
walter@remigesventures.com

SOURCE Remiges Ventures, Inc.